Platelet Factor 4 (PF4) Release during Human Platelet Aggregation in Diabetic Patients

J Chmielewski; R Farbiszewski

doi:10.1055/s-0038-1654225

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1970; 24(01/02): 203-205
DOI: 10.1055/s-0038-1654225

Originalarbeiten – Original Articles – Travaux Originaux

Schattauer GmbH

Platelet Factor 4 (PF₄) Release during Human Platelet Aggregation in Diabetic Patients

J Chmielewski

¹Second Department of Internal Diseases and Department of Physiological Chemistry Medical School, Bialystole, Poland

,

R Farbiszewski

¹Second Department of Internal Diseases and Department of Physiological Chemistry Medical School, Bialystole, Poland

› Author Affiliations

Abstract

Summary

The release of platelet factor 4 during platelet aggregation was investigated in diabetic patients. We observed an increased release of platelet factor 4 in diabetic patients.

The authors suggest that the increased release of platelet factor 4 may play an essential role in pathogenesis of thromboembolic complications in diabetes mellitus.

Full Text

References

References
1 Bielawiec M, Mysliwiec M, Perzanowski A. Zachowanie siç adhezji plytek krwi u chorych na cukrzycç. Pol. Arch. Med. Wewn 14: 19 1970;
2 Born G. V. Aggregation of blood platelets by ADP and its reversal. Nature (Lond.) 194: 927 1962;
3 Breddin K, Bauke J. Thrombocytenagglntination und Gefäßkrankheiten. Blut 11: 144 1965;
4 Ghmielewski J. Adhezja i agregacja piytek u chorych na cukrzycç. XIX Konferencja Naukowa Sekcji Diabetologicznej. TIP. Katowice. 1969
5 Egeberg O. The blood coagulability in diabetic patients. Scand. J. clin. Lab. Invest 15: 533 1963;
6 Farbiszewski R, Worowski K. The effect of modified betalipoproteins on adhesiveness and on aggregation of blood platelets. J. atheroscler. Res 09: 339 1969;
7 Farbiszewski R, Lipinski B, Niewiarowski S, Poplawski A. Hypercoagulability and thrombocytopenia after platelet factor 4 infusion into rabbits. Experientia (Basel.) 24: 578 1968;
8 Farbiszewski R, Worowski K. Enhacement of platelet aggregation and adhesiveness by beta-lipoproteins. J. atheroscler. Res 08: 988 1968;
9 Mayne E, Wearer J. A, Bridges J. M. A study of platelet adhesiones in diabetes mellitus. Diabetol 04: 377 1968; (Abstract).
10 Niewiarowski S, Poplawski A, Lipinski B, Farbiszewski R. The release of platelet clotting factors during aggregation and viscons metamorphosis. Exp. Biol. Med 03: 121 1968;
11 Niewiarowski S, Lipinski B, Farbiszewski R, Poplawski A. The release of platelet factor 4 during platelet aggregation and the possible significance of this reaction in hemostasis. Experientia (Basel.) 24: 343 1968;
12 Niewiarowski S, Farbiszewski R, Poplawski A, Lipinski B. Further investigations on the role of platelet factor 4 (PF₄) in the mechanism of platelet aggregation in metabolism and membrane permeability of erythrocytes and thrombocytes. 314 G. Thieme; Stuttgart: 1968
13 Pegrum G. D, Wolff S, Ashton W. L. Platelet adhesiveness in diabetes mellitus. J. clin. Path 20: 845 1967;
14 Valdorf-Hansen F. Thrombocytoses and coagulability in diabetes. Dan. med. Bull 14: 244 1967;
15 Youssef A, Barkham P. Release of platelet factor 4 by adenosine diphosphate and other platelet aggregating agents. Brit. Med. J 01: 746 1968;